Recurrent Thrombotic Events after Discontinuation of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort Study

It is generally recommended that patients with splanchnic vein thrombosis (SVT) should receive a minimum of 3 months of anticoagulant treatment. However, little information is available on the long-term risk of recurrent thrombotic events. The aim of this study was to evaluate the risk of venous and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gastroenterol Res Pract
Main Authors: Riva, Nicoletta, Ageno, Walter, Poli, Daniela, Testa, Sophie, Rupoli, Serena, Santoro, Rita, Lerede, Teresa, Piana, Antonietta, Carpenedo, Monica, Nicolini, Alberto, Ferrini, Piera Maria, Martini, Giuliana, Mangione, Catello, Contino, Laura, Bonfanti, Carlo, Gresele, Paolo, Tosetto, Alberto
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2015
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4609867/
https://ncbi.nlm.nih.gov/pubmed/26508913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/620217
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados